EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation

Amogh Gorantla iD, Jacques T V E Hall, Anneliese Troidle, Jelena M Janjic

Micromachines · 15.04.2024 · 15 (4) · 533

DOI: 10.3390/mi15040533 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Micromachines, online erschienen am 15.04.2024. Verfasst von Amogh Gorantla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering, Wake Forest University, Winston-Salem, NC 27109, USA. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of biomaterials for protein delivery is an emerging field that spans materials science, bioengineering, and medicine. In this review, we highlight the immense potential of protein-delivering biomaterials as therapeutic options and discuss the multifaceted challenges inherent to the field. We address current advancements and approaches in protein delivery that leverage stimuli-responsive materials, harness advanced fabrication techniques like 3D printing, and integrate nanotechnologies for greater targeting and improved stability, efficacy, and tolerability profiles. We also discuss the demand for highly complex delivery systems to maintain structural integrity and functionality of the protein payload. Finally, we discuss barriers to clinical translation, such as biocompatibility, immunogenicity, achieving reliable controlled release, efficient and targeted delivery, stability issues, scalability of production, and navigating the regulatory landscape for such materials. Overall, this review summarizes insights from a survey of the current literature and sheds light on the interplay between innovation and the practical implementation of biomaterials for protein delivery.

Schlagwörter

Stichwörter der Autor:innen

biomaterialsclinical translationprotein therapeutics

Autor:innen und Institutionen

  • Department of Engineering, Wake Forest University, Winston-Salem, NC 27109, USA.
  • Department of Chemistry, Duke University, Durham, NC 27708, USA.
  • School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA.

ORCID-Profile: Amogh Gorantla

Zitieren

APA

Gorantla, A., Hall, J. T. V. E., Troidle, A., & Janjic, J. M. (2024). Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation. Micromachines, 15(4), 533. https://doi.org/10.3390/mi15040533

Vancouver

Gorantla A, Hall JTVE, Troidle A, Janjic JM. Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation. Micromachines. 2024;15(4):533. doi:10.3390/mi15040533

BibTeX
@article{Gorantla2024,
  author = {Gorantla, Amogh and Hall, Jacques T V E and Troidle, Anneliese and Janjic, Jelena M},
  title = {Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation},
  journal = {Micromachines},
  year = {2024},
  volume = {15},
  number = {4},
  pages = {533},
  doi = {10.3390/mi15040533}
}
Kostenlos starten →